Cargando…
Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations
Diabetic kidney disease (DKD) affects approximately one-third of patients with diabetes and taking into consideration the high cardiovascular risk burden associated to this condition a multifactorial therapeutic approach is traditionally recommended, in which glucose and blood pressure control play...
Autores principales: | Leoncini, Giovanna, Viazzi, Francesca, De Cosmo, Salvatore, Russo, Giuseppina, Fioretto, Paola, Pontremoli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557495/ https://www.ncbi.nlm.nih.gov/pubmed/32681470 http://dx.doi.org/10.1007/s40620-020-00803-3 |
Ejemplares similares
-
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach
por: Bonino, Barbara, et al.
Publicado: (2019) -
Resistant Hypertension, Time‐Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus
por: Viazzi, Francesca, et al.
Publicado: (2017) -
Diabetic kidney disease in the elderly: prevalence and clinical correlates
por: Russo, Giuseppina T., et al.
Publicado: (2018) -
Normoalbuminuric kidney impairment in patients with T1DM: insights from annals initiative
por: Lamacchia, Olga, et al.
Publicado: (2018) -
Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney
por: Viazzi, Francesca, et al.
Publicado: (2013)